From: Trastuzumab immunogenicity development in patients’ sera and in laboratory animals
Serum dilutions | % Cytotoxicity | |||||||
---|---|---|---|---|---|---|---|---|
Control | 1st Regimen | 2nd Regimen | 3rd Regimen | |||||
Value | ±SD | Value | ±SD | Value | ±SD | Value | ±SD | |
0 | 36.89 | 0.08 | 36.89 | 0.08 | 36.89 | 0.08 | 36.89 | 0.08 |
1:20 | 49.19 | 0.12 | 29.88 | 0.05 | 34.19 | 0.04 | ||
1:100 | 12.12 | 0.27 | 1.49 | 0.12 | 25.98 | 0.10 | ||
1:200 | 0.76 | 0.15 | 13.71 | 0.02 | 50.22 | 0.08 |